fbpx ECRAN Project: a cartoon to describe clinical trials | Page 110 | Science in the net

ECRAN Project: a cartoon to describe clinical trials

Read time: 1 min

In 1747, there were many conflicting ideas and questions without answers about the cure for scurvy, a lethal kind of disease at the time. James Lind, surgeon of the Scottish navy, decided to face such an uncertainty by subjecting his patients to a clinical study, in order to compare six possible remedies. This experimentation showed that oranges and lemons were by far the best cure. His work not only saved the life of his ship's sailors, but also laid the foundations for modern clinical trials (randomized and controlled), as we know them today.

This is the reason why Lind's adventure starts the informative video on independent clinical research, realized by the European Communication Research Awareness Needs (ECRAN). The European project ECRAN, coordinated by the Istituto Mario Negri of Milan, in collaboration with eminent international partners, aims to disseminate information on independent clinical research within European citizens, through the realization of different kinds of informative and educational products. The cartoon produced by the project only lasts 5 minutes, is translated in 23 languages, is highly funny and captivating, and helps the public to understand the procedures followed during a clinical trial. International and independent clinical trials represent a fundamental contribute to clinical research, in order to find proper response on diagnosis, operations and prognosis.

[video: http://vimeo.com/69337236#at=0]

Autori: 
Sezioni: 
Ecran Project

prossimo articolo

Italy on the first line against Multiple Sclerosis

Italy is one of the most important country concerning the research on multiple sclerosis and the latest news about it come from the recent annual ACTRIMS-ECTRIMS meeting in Boston. A collaborative group led by Massimiliano Calabrese from the University of Verona was amongst the 20 funded projects across the world from the first announcement of Progressive MS Alliance – an international alliance of associations on MS, formed to accelerate the